TargED Biopharmaceuticals BV raises €39m...TargED Biopharmaceuticals will use €39m from a Series A financing to bring its thrombolytic treatment to patients. more ➔
Finnish VTT spin-out Onego Bio Ltd raises...The cellular agriculture spin-off Onego Bio Ltd has been seeded with €10m to use its Trichoderma platform to establish an animal-free egg protein production. more ➔
Moderna wants to extent its European footp...The former mRNA start-up Moderna Inc is set to expand its commercial network in six European nations to become a gobally active vaccine company. more ➔
Centauri Therapeutics starting with £24m... Antimicrobial resistance specialist Centauri Therapeutics Ltd has closed a £24m Series A round to identify novel therapeutic candidates using the Alphamer technology. more ➔
Curve Therapeutics in US$1.7bn deal with M...Curve Therapeutics has inked a contract with US pharma giant Merck & Co. (MSD) to screen novel small molecule drug candidates against five MSD targets. more ➔
Newton Biocapital launches new NBC III fun...Newton Biocapital has launched a new life sciences fund with initial capital commitments of €50m and a target size of €150m. more ➔
New funds to boost European life sciences European investment firm LSP has closed its European life sciences fund LSP at €1 bn. Additionally, a €10bn fund of funds was greenlighted at the EU Council in Paris. more ➔
Aicuris licences antisense RNA know-how fr...AiCuris will pay up to €100m to Dutch Hybridize Therapeutics BV for the development of antisense RNA therapeutics that stop BK viraemia in renal transplant patients. more ➔
BioNTech collaborates with AGC BiologicsAGC Biologics supports BioNTech’s manufacturing of an Omicron-based vaccine with plasmids for in vitro transcription. more ➔
EU Council confirms European Scale-up Init...EU Members States agreed on Tuesday to launch the pan-European Scale-up Initiative, which is aimed to provide €10bn for late-state tech companies. more ➔
